Sometimes what the AMA does makes some sense:
“A temporary moratorium on DTC advertising of prescribed drugs and medical devices will benefit both the patient and physician,” AMA President-elect Dr. Ronald M. Davis said in a prepared statement. “Physicians will have the opportunity to become better educated on the pros and cons of prescription drug uses before prescribing them, and will be better able to determine when they are best suited for their patients’ medical needs.”
